Wendell David Associates Inc / ABBV
Wendell David Associates Inc’s Abbvie Inc Position
Does Wendell David Associates Inc own Abbvie Inc (ABBV)? Yes — 95.5K shares worth $21M (+2.26% of its 13F portfolio) as of Q1 2026, down from 96.3K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
95.5K
% of Portfolio
+2.26%
Quarters Held
29
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 95.5K | $21M | +2.26% |
| Q4 2025 | 96.3K | $22M | +2.24% |
| Q3 2025 | 99.8K | $23M | +2.28% |
| Q2 2025 | 99.8K | $19M | +1.86% |
| Q1 2025 | 101.9K | $21M | +2.13% |
| Q4 2024 | 102.2K | $18M | +1.80% |
| Q3 2024 | 104.0K | $21M | +1.96% |
| Q2 2024 | 104.5K | $18M | +1.83% |
| Q1 2024 | 104.4K | $19M | +1.92% |
| Q4 2023 | 104.3K | $16M | +1.74% |
| Q3 2023 | 103.3K | $15M | +1.81% |
| Q2 2023 | 99.8K | $13M | +1.52% |
| Q1 2023 | 100.7K | $16M | +1.90% |
| Q4 2022 | 101.6K | $16M | +2.02% |
| Q3 2022 | 101.8K | $14M | +1.84% |
| Q2 2022 | 102.4K | $16M | +1.99% |
| Q1 2022 | 102.1K | $17M | +1.84% |
| Q4 2021 | 105.2K | $14M | +1.44% |
| Q3 2021 | 106.4K | $11M | +1.28% |
| Q2 2021 | 104.7K | $12M | +1.32% |
| Q1 2021 | 99.3K | $11M | +1.29% |
| Q4 2020 | 98.9K | $11M | +1.30% |
| Q3 2020 | 103.6K | $9M | +1.21% |
| Q2 2020 | 104.5K | $10M | +1.49% |
| Q1 2020 | 104.7K | $8M | +1.35% |
| Q4 2019 | 104.8K | $9M | +1.28% |
| Q3 2019 | 105.4K | $8M | +1.17% |
| Q2 2019 | 108.1K | $8M | +1.18% |
| Q1 2019 | 110.7K | $9M | +1.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wendell David Associates Inc’s full portfolio or all institutional holders of ABBV.